Filler Dissolving in Korea: Cost, Downtime and Hyaluronidase Risks

If you are unhappy with filler abroad, “just dissolve it” can sound like a clean reset. It is not that simple. The first questions are what material was injected, where it sits, and whether this is an elective correction or an emergency.

This article is part of our Korean cosmetic procedures guide. It explains planning, cost, downtime, and risks without endorsing a clinic or promising that your previous appearance can be restored exactly.

What filler dissolving can—and cannot—do

Hyaluronidase is an enzyme used in aesthetic practice to break down cross-linked hyaluronic-acid (HA) filler. It does not reliably remove every injectable material. Calcium hydroxylapatite, poly-L-lactic acid, permanent filler, fat, and an unknown product require a different assessment; surgery or another intervention may sometimes be considered.

The US FDA dermal-filler page warns that filler removal may require injections, surgery, or other procedures and may be difficult or impossible, especially for permanent or non-HA materials. US authorization does not govern Korean treatment, but this is useful safety context: confirm the product rather than assuming every lump is dissolvable HA.

Elective reasons may include overfilling, asymmetry, migration, a bluish Tyndall effect, or a persistent non-inflammatory lump. A painful, hot, red, draining, or late-swelling area needs diagnosis first. A 2024 consensus review of late HA-filler reactions distinguishes non-inflammatory problems from inflammatory or infectious presentations; automatically injecting hyaluronidase into every lump may be the wrong sequence.

Cost in Korea: request an itemized plan

There is no authoritative nationwide Korean tariff for cosmetic hyaluronidase treatment, so a promotional “per vial” price is not a reliable total or national average. Cost can change with the examination, treated area, presumed filler type and amount, number of sessions, medicine used, clinician, and whether ultrasound or urgent follow-up is needed.

Ask for a written Korean-won quote that separates:

• physician examination and diagnosis;
• hyaluronidase product, units or vials, and treated areas;
• ultrasound when clinically indicated, rather than sold as a universal requirement;
• medication, VAT, follow-up, and management of an adverse reaction;
• interpretation, accommodation, flexible flights, and follow-up after returning home.

An inexpensive first injection can become a poor-value plan if it excludes review or repeats. Do not choose the dose from a menu. Product composition and clinical purpose affect the plan, and emergency vascular-occlusion protocols are different from gradual elective correction.

Downtime and a realistic recovery plan

Needle discomfort, redness, tenderness, bruising, and swelling can follow treatment. Swelling can temporarily obscure whether enough filler was dissolved, while hyaluronidase may spread beyond a sharply defined cosmetic boundary. The American Society of Plastic Surgeons overview notes that partial dissolving can be difficult and lists pain, bleeding, bruising, swelling, redness, and allergic reaction among the considerations.

Do not schedule a refill, important photographs, or a fixed flight based on a guaranteed next-day result. Ask when the clinician wants to reassess you and when the appearance can be judged after swelling settles. Some cases need staged treatment; incomplete correction does not prove that an immediate large repeat dose is appropriate.

Keep your original filler record if possible: product and manufacturer, lot number, amount, injection sites, date, and previous complication treatment. Send it before traveling. If the product is unknown or the location is uncertain, ask how that uncertainty changes the plan.

Risks and emergency warning signs

Elective hyaluronidase injection is still a medical procedure. Possible problems include pain, bleeding, bruising, swelling, uneven or excessive volume reduction, incomplete effect, infection, and hypersensitivity. Severe allergic reaction is uncommon but can be life-threatening. Tell the clinician about previous reactions to hyaluronidase, bee or wasp stings, medicines, pregnancy or breastfeeding, bleeding disorders, and active skin or dental infection.

The FDA's 2025 dermal-filler removal review reported adverse-event submissions associated with hyaluronidase use, including swelling, burning, redness, excessive loss of volume, and lack of effect, and noted that its use to dissolve filler is not FDA-approved in the United States. That regulatory status should not be transplanted directly to Korea, but it reinforces the need for consent about uncertainty and alternatives.

Do not confuse an emergency with elective dissolving

After filler injection, severe or escalating pain, pale/grey/blue or net-like skin discoloration, new visual symptoms, facial weakness, speech difficulty, confusion, or other stroke signs require immediate emergency care. Filler entering a blood vessel can cause skin necrosis, blindness, or stroke. Do not fly, wait for swelling to settle, or book a routine appointment.

Ultrasound may help selected complex cases, but it is not a guarantee. A 2025 case series and systematic review described ultrasound-guided hyaluronidase for HA-filler arterial ischemia and found early intervention important; the evidence included a small case series and heterogeneous literature, so it should not be marketed as certain rescue.

Choosing a Korean clinic for assessment

Use the Korean clinic safety checklist, and ask:

1. Who will diagnose the problem and perform the injection?
2. How will you verify whether the original filler was HA?
3. Is this elective correction, suspected infection/inflammation, or an emergency?
4. What result is realistic, and what would make you stop or stage treatment?
5. How are allergic reaction and filler vascular occlusion handled on site?
6. Who reviews you after treatment and after you leave Korea?

International patients can check Korea's official Medical Korea registration system. Registration and malpractice-liability requirements are useful administrative safeguards, not guarantees of a cosmetic result.

FAQ

Can all filler be dissolved with hyaluronidase?

No. Hyaluronidase acts on HA. Other or unknown materials need identification and a different plan, and even HA correction may be incomplete or require another session.

Can only part of my filler be dissolved?

A clinician may attempt a conservative, staged correction, but enzyme spread and filler distribution make millimetre-perfect partial removal unrealistic. Discuss the trade-off between under-correction and unwanted volume loss.

Do I need ultrasound?

Not every straightforward elective case requires imaging. It may help locate filler or guide selected complex and vascular cases. Ask what decision the scan will change and who is qualified to interpret it.

When can I refill?

There is no universal interval. Swelling, tissue condition, the reason for dissolving, and the clinician's reassessment matter. Avoid a travel package that assumes dissolving and refilling must happen on consecutive days.

Is dissolving safer than leaving filler alone?

That depends on the diagnosis and symptoms. Observation may be reasonable for some cosmetic concerns; infection, inflammation, or vascular compromise needs a different response. A physician should compare the risks of treatment, waiting, and alternatives with you.

The practical decision

A safer plan starts with identification and diagnosis, not a discounted vial. Get records, allow time for reassessment, budget for follow-up, and know the emergency signs before treatment. Hyaluronidase can be valuable for HA filler, but it cannot guarantee a perfect reset.

This article is for general information only and is not medical advice. Results, recovery, risks, and costs vary. Consult a licensed, appropriately qualified medical professional before treatment.